Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Financial Flexibility Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of $68.82 Million (operating CF $41.05 Million minus capex $27.77 Million) represents 0% of total liabilities ($140.71 Million). Also explore Zhengye Biotechnology Holding Limited Or (ZYBT) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Check how resilient are Zhengye Biotechnology Holding Limited Or's assets to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year free cash flow to debt coverage for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full company profile including market capitalisation, see Zhengye Biotechnology Holding Limited Or (ZYBT) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +0.0% |
| 2024 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +31.4% |
| 2023 | 0.37x | $59.78 Million | $48.18 Million | $160.62 Million | ▲ +35.7% |
| 2022 | 0.27x | $44.66 Million | $17.34 Million | $162.81 Million | ▼ -40.4% |
| 2021 | 0.46x | $58.20 Million | $31.81 Million | $126.44 Million | — |